Michelle Manning and Steph Habif
To evaluate patient experience of Basal-IQ® technology during real-world use. While the patient experience scores reported in clinical trials are important, real-world use provides enhanced data insights to estimate ongoing sustainability and usefulness of diabetes technologies.
In May 2019, users of the t:slim X2 insulin pump with Basal-IQ technology voluntarily responded to an online survey via Qualtrics, an online survey software. Nine metrics measured satisfaction, trust, usability, and utility of the system on a 5-point Likert scale.
Participants reported high levels of satisfaction, trust, and overall usability. Survey findings showed that users perceived that the system has helped improved their sleep and overall blood glucose control. Results did not vary by age or prior therapy.
Study findings supported a very positive real-world experience of Basal-IQ technology in a large sample of users. Patient satisfaction with diabetes device technology has shown to be a critical factor in successful long-term diabetes management.